July 15 (Reuters) - Longview Acquisition Corp II :
* HEARTFLOW, THE LEADER IN PRECISION HEART CARE, ANNOUNCES MERGER WITH LONGVIEW ACQUISITION CORP. II TO BECOME A PUBLICLY TRADED COMPANY
* LONGVIEW ACQUISITION CORP II - COMBINED PRO FORMA ENTERPRISE VALUE IS APPROXIMATELY $2.4 BILLION
* LONGVIEW ACQUISITION CORP II - TRANSACTION SUPPORTED BY EXISTING INSTITUTIONAL SHAREHOLDERS
* LONGVIEW ACQUISITION CORP II - DEAL WILL ALSO PROVIDE COMBINED COMPANY WITH AN ESTIMATED $400 MILLION IN CASH FOR GROWTH CAPITAL
* LONGVIEW ACQUISITION CORP II - DEAL EXPECTED TO DELIVER UP TO $599 MILLION OF GROSS PROCEEDS TO HEARTFLOW
* LONGVIEW ACQUISITION CORP II - ANY EXCESS CASH IN TRUST TO BE DISTRIBUTED BY CO TO SHAREHOLDERS THROUGH SPECIAL DIVIDEND OF UP TO $91 MILLION PRIOR TO CLOSING
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。